Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.

Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.

Over the last decade, poxviral vectors emerged as a mainstay approach for the induction of T cell-mediated immunity by vaccination, and their suitability for human use has led to widespread clinical testing of candidate vectors against infectious intracellular pathogens and cancer. In contrast, poxv...

Bibliográfalaš dieđut
Váldodahkkit:	Draper, S, Cottingham, MG, Gilbert, S
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2013

Geahča maid

Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets.
Dahkki: de Cassan, S, et al.
Almmustuhtton: (2013)

Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass.
Dahkki: Alcock, R, et al.
Almmustuhtton: (2010)

Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA.
Dahkki: Orubu, T, et al.
Almmustuhtton: (2012)

Poxviral Ankyrin Proteins
Dahkki: Michael H. Herbert, et al.
Almmustuhtton: (2015-02-01)

Poxviral promoters for improving the immunogenicity of MVA delivered vaccines
Dahkki: Naif Khalaf Alharbi
Almmustuhtton: (2019-01-01)

Effective induction of high-titer antibodies by viral vector vaccines.
Dahkki: Draper, S, et al.
Almmustuhtton: (2008)

Methods of treating Poxviral Infections
Dahkki: Ramstedt, U, et al.
Almmustuhtton: (2011)

Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA.
Dahkki: Toritse Orubu, et al.
Almmustuhtton: (2012-01-01)

Poxviral Strategies to Overcome Host Cell Apoptosis
Dahkki: Chathura D. Suraweera, et al.
Almmustuhtton: (2020-12-01)

Poxviral Targeting of Interferon Regulatory Factor Activation
Dahkki: Clara Lawler, et al.
Almmustuhtton: (2020-10-01)

Prime-boost vectored malaria vaccines: progress and prospects.
Dahkki: Hill, A, et al.
Almmustuhtton: (2010)

Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen
Dahkki: Sheerin, D, et al.
Almmustuhtton: (2021)

Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen
Dahkki: Dylan Sheerin, et al.
Almmustuhtton: (2021-10-01)

New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1.
Dahkki: Goodman, A, et al.
Almmustuhtton: (2010)

Nodular Dermatitis: Emergence of Novel Poxviral Infection in Russia
Dahkki: S. V. Borisevich, et al.
Almmustuhtton: (2018-04-01)

Origin of the poxviral membrane: A 50-year-old riddle.
Dahkki: Bernard Moss
Almmustuhtton: (2018-06-01)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
Dahkki: Dicks, M, et al.
Almmustuhtton: (2011)

Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection.
Dahkki: Jarmila Knitlova, et al.
Almmustuhtton: (2014-01-01)

New Candidate Vaccines against Blood-Stage Plasmodium falciparum Malaria: Prime-Boost Immunization Regimens Incorporating Human and Simian Adenoviral Vectors and Poxviral Vectors Expressing an Optimized Antigen Based on Merozoite Surface Protein 1, (vol 78, pg 4610, 2010)
Dahkki: Goodman, A, et al.
Almmustuhtton: (2011)

Poxviral ANKR/F-box Proteins: Substrate Adapters for Ubiquitylation and More
Dahkki: Robert J. Ingham, et al.
Almmustuhtton: (2022-08-01)

T cell inactivation by poxviral B22 family proteins increases viral virulence.
Dahkki: Dina Alzhanova, et al.
Almmustuhtton: (2014-05-01)

Rapid generation of markerless recombinant MVA vaccines by en passant recombineering of a self-excising bacterial artificial chromosome.
Dahkki: Cottingham, MG, et al.
Almmustuhtton: (2010)

Viral vectors as vaccine platforms: Deployment in sight
Dahkki: Rollier, C, et al.
Almmustuhtton: (2011)

Viral vectors as vaccine platforms: deployment in sight.
Dahkki: Rollier, C, et al.
Almmustuhtton: (2011)

Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara.
Dahkki: Smith, C, et al.
Almmustuhtton: (2005)

Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry.
Dahkki: Skinner, M, et al.
Almmustuhtton: (2005)

Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice
Dahkki: Martin C. Langenmayer, et al.
Almmustuhtton: (2023-06-01)

Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin.
Dahkki: Mostafa Jarahian, et al.
Almmustuhtton: (2011-08-01)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
Dahkki: Biswas, S, et al.
Almmustuhtton: (2011)

Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter
Dahkki: Alharbi, N, et al.
Almmustuhtton: (2015)

Viruses as vaccine vectors for infectious diseases and cancer.
Dahkki: Draper, S, et al.
Almmustuhtton: (2010)

Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.
Dahkki: Guzman, E, et al.
Almmustuhtton: (2012)

Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV
Dahkki: Sarah Wilmschen, et al.
Almmustuhtton: (2019-09-01)

New vectored vaccines for malaria.
Dahkki: Hill, A, et al.
Almmustuhtton: (2008)

SECRET domain of variola virus CrmB protein can be a member of poxviral type II chemokine-binding proteins family
Dahkki: Shchelkunov Sergei N, et al.
Almmustuhtton: (2010-10-01)

Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
Dahkki: Ewer, K, et al.
Almmustuhtton: (2015)

Different levels of immunogenicity of two strains of Fowlpox virus as recombinant vaccine vectors eliciting T-cell responses in heterologous prime-boost vaccination strategies.
Dahkki: Cottingham, MG, et al.
Almmustuhtton: (2006)

Discovery of a heparan sulfate binding domain in monkeypox virus H3 as an anti-poxviral drug target combining AI and MD simulations
Dahkki: Bin Zheng, et al.
Almmustuhtton: (2025-01-01)

Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection.
Dahkki: Biswas, S, et al.
Almmustuhtton: (2012)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors.
Dahkki: Cottingham, MG, et al.
Almmustuhtton: (2012)